Skip to content

GI Cancer Icon Changing outcomes for people with GIgastro-intestinal cancer since 1991

Donate Now
  • Make a Single Gift
  • Give a Monthly Gift
  • Give In Memory
  • A Gift In Your Will
  • Fundraise For Us
MENUMENU
  • Home
  • About
    • About Us
      • Chair’s Message
      • Board of Directors
      • Staff Members
      • Governance
      • Employment Opportunities
      • Our impact
      • Annual Reports
      • Scientific Advisory Committee
      • Community Advisory Panel
      • International Development Committee
      • Translational Research Committee
      • New Zealand Committee
      • Research Operations Committee
      • Upper GI and Lower GI Working Parties
      • Corporate Support
  • GI Cancer
    • What is GI cancer?
      • Oesophageal Cancer
      • Liver Cancer
      • Stomach Cancer
      • Gallbladder & Biliary Tract Cancer
      • Pancreatic Cancer
      • Gastro-Intestinal Stromal Tumour (GIST)
      • Neuroendocrine Tumours (NETs)
      • Colorectal Cancer
      • Rectal Cancer
      • Small Bowel Cancer
      • Anal Cancer
    • Resources
      • Videos
      • Webinars
      • Cancer FAQ
      • Support Groups
      • Recommended Reading
      • Information Booklets
      • Recipes
      • Helpful Links
      • Newsletter Sign-up
    • News
      • Stories
      • Community Forums
  • Trials & Research
    • Clinical Trials
      • Trial Recruitment
      • Concepts - In Development
      • Trials - In Development
      • Trials - Open
      • Trials - In Follow-up
      • Trials - Completed
      • Trials - Substudies
      • Trials - Endorsed Studies
      • Participating Trial Centres
      • Clinical Trial FAQs
      • Genesis of a Clinical Trial
    • Research
      • Developing our Research
      • Research Priorities
      • Upper GI and Lower GI Working Parties
      • Idea Generation Workshop
      • Endorsed Study Model
      • Translational Research
      • Translational Research Model
      • Tele-Trial Model
      • Publications and Presentations
  • Health Professionals
    • AGITG
      • Become a Member
      • Member Spotlight
      • Our impact
      • Funding
    • Awards and Grants
      • Innovation Grant
      • Rectal Cancer Research Grant
      • Philanthropic Funding
      • Merck-AGITG Clinical Research Fellowship in GI Cancer
      • New Concepts Symposium
      • Best of Posters & Fast Forward
      • Outstanding Site Award
      • John Zalcberg OAM Award
      • Christine Aiken Memorial Award for Excellence in AGITG Study Coordination
      • AGITG Member Fundraiser of the Year Award
      • Grant Opportunities
      • Early Career Research Award for Excellence in AGITG Research
    • CommNETs
      • Presentations & Publications
      • Projects & Working Groups
      • Newsletters
      • Annual Research Workshop
      • CommNETs Committees
      • CommNETs Committee
      • Preceptorships
      • Policies
      • Contacts
    • News
      • Events & Education
        • Annual Scientific Meeting
  • ASM
  • Get Involved
    • The Gutsy Challenge
      • 2023 Gutsy Challenge Adventures
      • Blue Mountains Gutsy Challenge 2023
      • Past Gutsy Challenge Adventures
    • Fundraise
      • Start a Gutsy Fundraiser
      • Walk, Run or Ride for Research
      • Raise Your Fork for Research
      • Create Your Own Event
      • Workplace Fundraising Ideas
    • Donate
      • Where Does My Gift Go?
      • Make a Single Gift
      • Give a Monthly Gift
      • Direct Deposit Donation
      • A Gift In Your Will
      • Give In Memory
      • Workplace Giving
    • Volunteer
      • Corporate Support
  • Contact
  • Newsletter Sign-up
  • Member Login
GI Cancer Banner Image

Projects & Working Groups

CommNETs is funded by Sponsorship provided by Ipsen Australia and an Education Grant provided by Ipsen Canada

  • COMMNETS MENU

Completed Projects

  • CommNETs Surgical Symposia

A six-part surgical management of small bowel NET series of publications. Members: Jonathan Koea, Janice Pasieka, Julie Hallet, Calvin Law,  N.S. Rajaretnam, G.Y. Meyer-Rochow.

  • Pituitary function following peptide receptor radionuclide therapy for NETs

Multi-centre cohort study of pituitary profile in patients with unresectable NETs who had received PRRT at least 2 years ago. Members: Marianne Elston, Amanda Love, Dev Kevat, Richard Carroll, Zhen Rong Siow, Sharon Pattison, Veronica Boyle, Eva Segelov, Andrew Strickland, David Wyld, Richard Gauci, Kim Kennedy, David Random.

  • CommNETs/NANETS Endorsement and Update of ENETS Pulmonary NET Guidelines

Click here for publication

CommNETs collaborated with the North American Neuroendocrine Tumour Society (NANETS) to review the methodology and content of the existing European Neuroendocrine Tumour Society (ENETS) guidelines on lung NET diagnosis and management. A consensus update was produced to guide clinical management and direct research efforts within the increasing lung neuroendocrine tumour population. Members: Simron Singh, K. Bergsland, Cynthia M. Card, Thomas A. Hope, Pamela L. Kunz, David T. Laidley, Ben Lawrence, Simone Leyden, Michael Michael, Lucy E. Modahl, Sten Myrehaug, Sukhmani K. Padda, Rodney F. Pommier, Robert A. Ramirez, Michael Soulen, Jonathan Strosberg, Alia Thawer, Benjamin Wei, Bin Xu, Eva Segelov.

  • Financial Outcomes in People with NETs (Australia)

Click here for publication

A cross-sectional study using an online survey and exploratory analysis of Ministry of Health data to assess financial burden experienced by neuroendocrine patients. Investigators: David Wyld, John Leyden. Members: Kate Wakelin, Simone Leyden, Louisa Gordon, Jan Mumford, Nick Pavlakis, Michael Michael, David Chan.

  • NET Indicators

Click here for publication

A dual round Delphi consensus mechanism, first round online and second round face to face expert focus group, were conducted to develop a small set of NET indicators that can be used to measure quality of care of people with NETs in Australia, New Zealand, and Canada.

  • A Modified Delphi Process to Identify and Prioritize Gaps in NET Research

Click here for publication

A three-round modified Delphi process was undertaken to identify gaps in NET research and develop a well-founded set of research priorities to influence the CommNETs research agenda and action plan.

  • Availability and Utility of Functional Imaging and PRRT in the CommNETs Collaboration.

Click here for poster presentation

CommNETs centres were surveyed to compare the availability and accessibility of functional imaging and peptide receptor radionuclide therapy along with current practices and preferences, identifying a need for improved access and best practice guidelines.

  • Follow-Up Recommendations for Completely Resected Gastroenteropancreatic NETs

Resulting publications:

https://jamanetwork.com/journals/jamaoncology/fullarticle/2688522

https://www.karger.com/Article/Abstract/488394

https://jamanetwork.com/journals/jamaoncology/fullarticle/2675009

CommNETs and the North American Neuroendocrine Tumour Society (NANETS) collaborated to generate patient-centered follow-up recommendations for completely resected gastroenteropancreatic NETs. The recommendations stratify follow-up strategies based on evidence-based prognostic factors that allow for an individualized approach to this complex and heterogeneous malignant neoplasm.

  • Why are there so few Surgical Trials in NETs?

Editorial publication pending. Surgical perspective summarizing the barriers to conduct surgical trials in neuroendocrine tumours, particularly gastrointestinal and pancreatic NETs. Investigators: Jonathan Koea, Jenny Choi.

  • Barriers to Indigenous Peoples Participation in Biobanking Genomic Research

Click here for publication.

A literature review was conducted to define the barriers to indigenous peoples participating in biobanking, tissue banking, and genomic research. Four recommendations were identified for the consideration of researchers working with this patient population.


Current Projects

  • Investigation into the relationship between tumour aneuploidy and prognosis for patient with pancreatic neuroendocrine tumour 

In this project we will evaluate the prognostic value of LoH/MEN1 mutation analysis on an expanded
set of tumours through international collaboration with the aim of deriving a biomarker to guide clinical decision making. Deborah Wright, Julie Hallet, Benjamin Lawrence, Cristin Print, Jonathan Koea, Paula Shields, Peter Tsai.

  • A CommNETs multi-country, cross-sectional survey of cognitive functions reported by neuroendocrine patients compared to their caregivers

Describe cognitive functions of people with metastatic stage IV NETs at first presentation to an oncology medical practitioner, assess correlation between Frontal Systems Behaviour (FrSBE) and FACT Cog score, and investigate correlation between patient and caregiver FrSBE scores. Janice Pasieka, Rachel Goodwin.

  • Hepatic cytoreduction for metastatic NET: A comparison of two eras – pre and post metabolic imaging

Systematic review to assess the results of hepatic cytoreductive surgery patients undergoing staging with DOTATATE PET vs. historical group staged with standard contrast enhanced CT. Members: Jonathan Koea, Sanket Srinivasa.

  • Design and Creation of an Optimal Shared Care Model for NET Patients in the Community

Publication pending. A literature search, surveys, and advisory board meetings with NET oncologists and surgeons were conducted to develop a shared care model to streamline the transition of care between NET specialty centres and care providers outside of these centres. Investigators: Radhika Yelamanchili, Dorothy Lo, Alia Thawer, David Wyld, Warren Fingrut, David Chan, Simron Singh. Members: Harsh Naik.

  • Quality of Life with PRRT

A retrospective audit of patients with unresectable metastatic neuroendocrine neoplasms treated with peptide receptor radionuclide therapy (PRRT) to assess if PRRT improves or maintains global health status. Investigator: Gabrielle Cehic. Members: Nadia Corsini, Grace Kong, Annette Hogg, Petra Marusic, Dale Bailey, Bryan Chan, Aimee Hayes, Dainik Patel.

  • Paediatric, Adolescent and Young Adult (PAYA) NETs

The NETwork! Registry will be used to describe the incidence and characteristics of NETs in the PAYA population in New Zealand and explore the patterns of care compared to current adult guidelines. A comparison will also be made with the Queensland NET registry to compare incidence, anatomical site of origin and outcome across countries. Investigators: Sharon Pattison, Kate Parker, David Wyld. Members: Ruellyn Cockroft.

  • Using Discrete Choice Experiments to Understand the Treatment Preferences of Patients with NETs

Patients will be surveyed using three clinical scenarios for which there is often uncertainty in treatment decision-making to explore relative utility values for treatment attributes, ranking of patient preferences in treatment, and subgrouping based on patient demographics using 1000 Minds Software. Investigators: Matthew Anaka, Simron Singh. Members: David Chan, Lesley Moody, Eva Segelov, Nick Pavlakis, Chris Jackson.

  • Surgical Controversies in NETs: Determinants of Surgical Decision Making

1000 Minds software will be used to review reasoning and modifiers behind surgical decision making in three key areas of NET surgical treatment where there is lack of trial evidence available to inform clinicians. Investigators: Jonathan Koea, Sharon Pattison.

  • Familial NET Registry

The goal of this project is to create a national registry of patients and their families in New Zealand with germline mutations resulting in familial NET syndromes, including MEN1 and phaeochromocytoma/paraganglioma syndromes, to facilitate investigator led clinical research, guidance on the appropriate use of genetic testing, inform biochemical and radiological surveillance programs, and standardize clinical practice. Investigator: Richard Carroll. Members: Marianne Elston, Amanda Love.

  • Financial Outcomes in People with NETs (New Zealand)

A cross-sectional online survey and Ministry of Health data will be used to assess financial burden experienced by neuroendocrine patients. Investigators: Sharon Pattison, Trudy Sullivan. Members: Gwen Pinches, Chris Jackson, William Leung, David Wyld, Louisa Gordon.


Developing Projects

There are a number of projects currently in development within CommNETs.

 

 

Share

© Copyright AGITG 2017 Privacy Terms and Conditions

Registered Charity
Gastro Intestinal Cancer Institute Logo
  • Home
  • About
    • About Us
      • Chair’s Message
      • Board of Directors
      • Staff Members
      • Governance
      • Employment Opportunities
      • Our impact
      • Annual Reports
      • Scientific Advisory Committee
      • Community Advisory Panel
      • International Development Committee
      • Translational Research Committee
      • New Zealand Committee
      • Research Operations Committee
      • Upper GI and Lower GI Working Parties
      • Corporate Support
  • GI Cancer
    • What is GI cancer?
      • Oesophageal Cancer
      • Liver Cancer
      • Stomach Cancer
      • Gallbladder & Biliary Tract Cancer
      • Pancreatic Cancer
      • Gastro-Intestinal Stromal Tumour (GIST)
      • Neuroendocrine Tumours (NETs)
      • Colorectal Cancer
      • Rectal Cancer
      • Small Bowel Cancer
      • Anal Cancer
    • Resources
      • Videos
      • Webinars
      • Cancer FAQ
      • Support Groups
      • Recommended Reading
      • Information Booklets
      • Recipes
      • Helpful Links
      • Newsletter Sign-up
    • News
      • Stories
    • Engage
      • Community Forums
  • Trials & Research
    • Clinical Trials
      • Trial Recruitment
      • Concepts – In Development
      • Trials – In Development
      • Trials – Open
      • Trials – In Follow-up
      • Trials – Completed
      • Trials – Substudies
      • Trials – Endorsed Studies
      • Participating Trial Centres
      • Clinical Trial FAQs
      • Genesis of a Clinical Trial
    • Research
      • Developing our Research
      • Research Priorities
      • Upper GI and Lower GI Working Parties
      • Idea Generation Workshop
      • Endorsed Study Model
      • Translational Research
      • Translational Research Model
      • Tele-Trial Model
      • Publications and Presentations
  • Health Professionals
    • AGITG
      • Become a Member
      • Member Spotlight
      • Our impact
      • Funding
    • Awards and Grants
      • Innovation Grant
      • Rectal Cancer Research Grant
      • Philanthropic Funding
      • Merck-AGITG Clinical Research Fellowship in GI Cancer
      • New Concepts Symposium
      • Best of Posters & Fast Forward
      • Outstanding Site Award
      • John Zalcberg OAM Award
      • Christine Aiken Memorial Award for Excellence in AGITG Study Coordination
      • AGITG Member Fundraiser of the Year Award
      • Grant Opportunities
      • Early Career Research Award for Excellence in AGITG Research
    • CommNETs
      • Presentations & Publications
      • Projects & Working Groups
      • Newsletters
      • Annual Research Workshop
      • CommNETs Committees
      • CommNETs Committee
      • Preceptorships
      • Policies
      • Contacts
    • News
      • Events & Education
        • Annual Scientific Meeting
  • ASM
  • Get Involved
    • The Gutsy Challenge
      • 2023 Gutsy Challenge Adventures
      • Blue Mountains Gutsy Challenge 2023
      • Mt Himlung Himal Ascent – Nepal 2021
      • Past Gutsy Challenge Adventures
    • Fundraise
      • Start a Gutsy Fundraiser
      • Walk, Run or Ride for Research
      • Raise Your Fork for Research
      • Create Your Own Event
      • Workplace Fundraising Ideas
    • Donate
      • Where Does My Gift Go?
      • Make a Single Gift
      • Give a Monthly Gift
      • Direct Deposit Donation
      • A Gift In Your Will
      • Give In Memory
      • Workplace Giving
    • Volunteer
      • Corporate Support
  • Contact

GI Cancer Icon Changing outcomes for people with GIgastro-intestinal cancer since 1991

Donate Now